ACE and heart failure: Other changes included adding angiotensin-receptor blocker therapy (ARB) as an alternative to angiotensin-converting enzyme inhibitor (ACEI) therapy in 2005 to the AMI and heart failure measures ACEI or ARB for left ventricular dysfunction.